Most of known Egr-1 targets are genes involved in tumor metastasis, such as plasminogen activator inhibitor-1 (PAI-1) [19], Transforming Growth Factor-beta 1 (TGF-β1) [20], and matrix metalloporteinase-9 (MMP-9) [21]. This evidence concerns the gene SERPINE1 and neoplasm.